Assignee
IMMORNA HANGZHOU BIOTECHNOLOGY CO LTD
CN·0 granted patents·5 pending applications·0 citations·filing 2021–2025
Top patents by PatentIndex Score
5 records- 0169US2024390484A1Rna formulations and lipidsIMMORNA HANGZHOU BIOTECHNOLOGY CO LTD·Filed 2024·Application pending·0 cites
- 0263US2024366740A1Interleukin-12 self-replicating rna and methodsIMMORNA HANGZHOU BIOTECHNOLOGY CO LTD·Filed 2024·Application pending·0 cites
- 0362US2026007738A1Self-replicating rna vaccines and methods of useIMMORNA HANGZHOU BIOTECHNOLOGY CO LTD·Filed 2025·Application pending·0 cites
- 0456US2025230196A1Modified self-replicating mrnaIMMORNA HANGZHOU BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 0554US2024307319A1Ionizable lipid molecule, preparation method therefor, and application thereof in preparation of lipid nanoparticleIMMORNA HANGZHOU BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IMMORNA HANGZHOU BIOTECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →